Skip to main content

Advertisement

SpringerLink
Log in

Enhanced Expression of Resistin-like Molecule Beta in Human Colon Cancer and Its Clinical Significance

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Previous studies have indicated that resistin-like molecule beta (RELMβ), an intestinal goblet cell-specific protein, is markedly increased in the intestinal tumors of min mice and over-expressed in a human colon cancer cell line. We hypothesized that RELMβ might be enhanced in human colon cancer. The aim of this study was to examine the clinical importance of RELMβ expression in colon cancer patients and to correlate its expression with various clinicopathological parameters, upstream regulatory molecule expression, tumor proliferative capacity, and patients’ survival. Of the 80 colon cancer patients studied, 65 (81.25%) tested positive for RELMβ, mainly in the cytoplasm of colon mucosa. Contrasting sharply with the strongly RELMβ-positive tumors, normal colon mucous membrane was negative or weakly positive. RELMβ positivity in colon cancer was correlated with histological grade of differentiation and lymph node metastasis, but not with age, gender, tumor location and size, tumor infiltration, Dukes’ stage, liver metastasis, and venous invasion. RELMβ expression was significantly correlated with the expression of transcription factor CDX-2 (P < 0.01) but not with that of proliferative index Ki-67 (P > 0.05). The mean postoperative survival time (2.76 years) of RELMβ-positive patients was significantly longer than that (1.26 years) of RELMβ-negative patients (P = 0.032). These findings support evidence of the enhanced RELMβ expression in colon cancer patients and suggest that further investigation is warranted to explore the role of RELMβ in colon cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Roy HK, Smyrk TC, Koetsier J, Victor TA, Wali RK (2005) The transcriptional repressor SNAIL is overexpressed in human colon cancer. Dig Dis Sci 50:42–46. doi:10.1007/s10620-005-1275-z

    Article  PubMed  CAS  Google Scholar 

  2. Uchino H, Kataoka H, Itoh H, Sekiya R, Onitsuka T, Koono M (1999) Roles of intestinal trefoil factor (ITF) in human colorectal cancer: ITF suppresses the growth of colorectal carcinoma cells. Hum Cell 12:181–188

    PubMed  CAS  Google Scholar 

  3. Laboisse C, Jarry A, Branka JE, Merlin D, Bou-Hanna C, Vallette G (1995) Regulation of mucin exocytosis from intestinal goblet cells. Biochem Soc Trans 23:810–813

    PubMed  CAS  Google Scholar 

  4. Poulsom R, Wright NA (1993) Trefoil peptides: a newly recognized family of epithelial mucin-associated molecules. Am J Physiol 265:G205–G213

    PubMed  CAS  Google Scholar 

  5. Aksoy N, Akinci OF (2004) Mucin macromolecules in normal, adenomatous, and carcinomatous colon: evidence for the neotransformation. Macromol Biosci 4:483–496. doi:10.1002/mabi.200300099

    Article  PubMed  CAS  Google Scholar 

  6. Byrd J, Bresalier R (2004) Mucins and mucin binding proteins in colorectal cancer. Cancer Metastasis Rev 23:77–99. doi:10.1023/A:1025815113599

    Article  PubMed  CAS  Google Scholar 

  7. Shaoul R, Okada Y, Cutz E, Marcon MA (2004) Colonic expression of MUC2, MUC5AC, and TFF1 in inflammatory bowel disease in children. J Pediatr Gastroenterol Nutr 38:488–493. doi:10.1097/00005176-200405000-00006

    Article  PubMed  CAS  Google Scholar 

  8. Taupin DR, Kinoshita K, Podolsky DK (2000) Intestinal trefoil factor confers colonic epithelial resistance to apoptosis. Proc Natl Acad Sci USA 97:799–804. doi:10.1073/pnas.97.2.799

    Article  PubMed  CAS  Google Scholar 

  9. Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, Enders GH, Silberg DG, Wen X, Wu GD, Lazar MA (2001) A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 98:502–506. doi:10.1073/pnas.98.2.502

    Article  PubMed  CAS  Google Scholar 

  10. Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HRP, Schad GA, Scott P, Wu GD (2004) RELM{beta}/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci USA 101:13596–13600. doi:10.1073/pnas.0404034101

    Article  PubMed  CAS  Google Scholar 

  11. Holcomb IN, Kabakoff RC, Chan B, Baker TW, Gurney A, Henzel W, Nelson C, Lowman HB, Wright BD, Skelton NJ, Frantz GD, Tumas DB, Peale J, Shelton DL, Hebert CC (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J 19:4046–4055. doi:10.1093/emboj/19.15.4046

    Article  PubMed  CAS  Google Scholar 

  12. He W, Wang ML, Jiang HQ, Steppan CM, Shin ME, Thurnheer MC, Cebra JJ, Lazar MA, Wu GD (2003) Bacterial colonization leads to the colonic secretion of RELMbeta/FIZZ2, a novel goblet cell-specific protein. Gastroenterology 125:1388–1397. doi:10.1016/j.gastro.2003.07.009

    Article  PubMed  CAS  Google Scholar 

  13. Steppan CM, Lazar MA (2004) The current biology of resistin. J Intern Med 255:439–447. doi:10.1111/j.1365-2796.2004.01306.x

    Article  PubMed  CAS  Google Scholar 

  14. Stutz AM, Pickart LA, Trifilieff A, Baumruker T, Prieschl-Strassmayr E, Woisetschlager M (2003) The Th2 cell cytokines IL-4 and IL-13 regulate found in inflammatory zone 1/resistin-like molecule alpha gene expression by a STAT6 and CCAAT/enhancer- binding protein-dependent mechanism. J Immunol 170:1789–1796

    PubMed  Google Scholar 

  15. Gerstmayer B, Kusters D, Gebel S, Muller T, Van Miert E, Hofmann K, Bosio A (2003) Identification of RELM[gamma], a novel resistin-like molecule with a distinct expression pattern. Genomics 81:588–595. doi:10.1016/S0888-7543(03)00070-3

    Article  PubMed  CAS  Google Scholar 

  16. Edelblum KL, Yan F, Yamaoka T, Polk DB (2006) Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 12(5):413–424. doi:10.1097/01.MIB.0000217334.30689.3e

    Article  PubMed  Google Scholar 

  17. de Santa Barbara P, van den Brink GR, Roberts DJ (2003) Development and differentiation of the intestinal epithelium. Cell Mol Life Sci 60:1322–1332. doi:10.1007/s00018-003-2289-3

    Article  PubMed  CAS  Google Scholar 

  18. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA (2007) MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 117:2313–2324. doi:10.1172/JCI26705

    Article  PubMed  CAS  Google Scholar 

  19. Moehle C, Ackermann N, Langmann T, Aslanidis C, Kel A, Kel-Margoulis O, Schmitz-Madry A, Zahn A, Stremmel W, Schmitz G (2006) Aberrant intestinal expression and allelic variants of mucin genes associated with inflammatory bowel disease. J Mol Med 84:1055–1066. doi:10.1007/s00109-006-0100-2

    Article  PubMed  CAS  Google Scholar 

  20. Sasaki M, Ikeda H, Nakanuma Y (2007) Expression profiles of MUC mucins and trefoil factor family (TFF) peptides in the intrahepatic biliary system: physiological distribution and pathological significance. Prog Histochem Cytochem 42:61–110. doi:10.1016/j.proghi.2007.02.001

    Article  PubMed  CAS  Google Scholar 

  21. Banerjee RR, Lazar MA (2001) Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J Biol Chem 276:25970–25973. doi:10.1074/jbc.M103109200

    Article  PubMed  CAS  Google Scholar 

  22. Kinoshita K, Taupin DR, Itoh H, Podolsky DK (2000) Distinct pathways of cell migration and antiapoptotic response to epithelial injury: structure-function analysis of human intestinal trefoil factor. Mol Cell Biol 20:4680–4690. doi:10.1128/MCB.20.13.4680-4690.2000

    Article  PubMed  CAS  Google Scholar 

  23. Wang ML, Shin ME, Knight PA, Artis D, Silberg DG, Suh E, Wu GD (2005) Regulation of RELM/FIZZ isoform expression by Cdx2 in response to innate and adaptive immune stimulation in the intestine. Am J Physiol Gastrointest Liver Physiol 288:G1074–G1083. doi:10.1152/ajpgi.00442.2004

    Article  PubMed  CAS  Google Scholar 

  24. Beck F (2004) The role of Cdx genes in the mammalian gut. Gut 53:1394–1396. doi:10.1136/gut.2003.038240

    Article  PubMed  CAS  Google Scholar 

  25. Freund JN, Domon-Dell C, Kedinger M, Duluc I (1998) The Cdx-1 and Cdx-2 homeobox genes in the intestine. Biochem Cell Biol 76:957–969. doi:10.1139/bcb-76-6-957

    Article  PubMed  CAS  Google Scholar 

  26. Li MK, Folpe AL (2004) CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Adv Anat Pathol 11:101–105. doi:10.1097/00125480-200403000-00004

    Article  PubMed  CAS  Google Scholar 

  27. Yamamoto H, Bai YQ, Yuasa Y (2003) Homeodomain protein CDX2 regulates goblet-specific MUC2 gene expression. Biochem Biophys Res Commun 300:813–818. doi:10.1016/S0006-291X(02)02935-2

    Article  PubMed  CAS  Google Scholar 

  28. Boudreau F, Rings EHHM, van Wering HM, Kim RK, Swain GP, Krasinski SD, Moffett J, Grand RJ, Suh ER, Traber PG (2002) Hepatocyte nuclear factor-1alpha, GATA-4, and caudal related homeodomain protein Cdx2 interact functionally to modulate intestinal gene transcription. Implication for the developmental regulation of the sucrase-isomaltase gene. J Biol Chem 277:31909–31917. doi:10.1074/jbc.M204622200

    Article  PubMed  CAS  Google Scholar 

  29. Drummond F, Sowden J, Morrison K, Edwards YH (1996) The caudal-type homeobox protein Cdx-2 binds to the colon promoter of the carbonic anhydrase 1 gene. Eur J Biochem 236:670–681. doi:10.1111/j.1432-1033.1996.t01-1-00670.x

    Article  PubMed  CAS  Google Scholar 

  30. Lorentz O, Duluc I, Arcangelis AD, Simon-Assmann P, Kedinger M, Freund JN (1997) Key role of the Cdx2 homeobox gene in extracellular matrix-mediated intestinal cell differentiation. J Cell Biol 139:1553–1565. doi:10.1083/jcb.139.6.1553

    Article  PubMed  CAS  Google Scholar 

  31. Sakaguchi T, Gu X, Golden HM, Suh E, Rhoads DB, Reinecker HC (2002) Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem 277:21361–21370. doi:10.1074/jbc.M110261200

    Article  PubMed  CAS  Google Scholar 

  32. Traber PG, Wu GD, Wang W (1992) Novel DNA-binding proteins regulate intestine-specific transcription of the sucrase-isomaltase gene. Mol Cell Biol 12:3614–3627

    PubMed  CAS  Google Scholar 

  33. Dang DT, Mahatan CS, Dang LH, Agboola IA, Yang VW (2001) Expression of the gut-enriched Krüppel-like factor (Krüppel-like factor 4) gene in the human colon cancer cell line RKO is dependent on CDX2. Oncogene 20:4884–4890. doi:10.1038/sj.onc.1204645

    Article  PubMed  CAS  Google Scholar 

  34. Marchetti M, Caliot E, Pringault E (2003) Chronic acid exposure leads to activation of the cdx2 intestinal homeobox gene in a long-term culture of mouse esophageal keratinocytes. J Cell Sci 116:1429–1436. doi:10.1242/jcs.00338

    Article  PubMed  CAS  Google Scholar 

  35. Phillips RW, Frierson HF Jr, Moskaluk CA (2003) Cdx2 as a marker of epithelial intestinal differentiation in the esophagus. Am J Surg Pathol 27:1442–1447. doi:10.1097/00000478-200311000-00006

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This work was supported by National Natural Science Foundation of China (No. 30200284, No. 30600278, No. 30772359) and the Program for New Century Excellent Talents in University of China (NCET-06-0641).

Author information

Authors and Affiliations

  1. Department of Pathology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province, China

    Li-Duan Zheng, Mi-Xia Weng & Jun He

  2. Department of Surgery, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province, China

    Qiang-Song Tong, Qing Lv, Jia-Rui Pu, Guo-Song Jiang, Jia-Bin Cai & Yuan Liu

  3. Department of Gastroenterology, Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, Hubei Province, China

    Xiao-Hua Hou

Authors
  1. Li-Duan Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Qiang-Song Tong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mi-Xia Weng
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Jun He
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Qing Lv
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jia-Rui Pu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Guo-Song Jiang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jia-Bin Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yuan Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xiao-Hua Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Qiang-Song Tong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zheng, LD., Tong, QS., Weng, MX. et al. Enhanced Expression of Resistin-like Molecule Beta in Human Colon Cancer and Its Clinical Significance. Dig Dis Sci 54, 274–281 (2009). https://doi.org/10.1007/s10620-008-0355-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-008-0355-2

Keywords

Search

Navigation